The role of gene–environment interactions in lung disease: the urgent need for the exposome

Craig E. Wheelock, Stephen M. Rappaport

Source: Eur Respir J, 55 (2) 1902064; 10.1183/13993003.02064-2019
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Craig E. Wheelock, Stephen M. Rappaport. The role of gene–environment interactions in lung disease: the urgent need for the exposome. Eur Respir J, 55 (2) 1902064; 10.1183/13993003.02064-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013

The exposome concept: a challenge and a potential driver for environmental health research
Source: Eur Respir Rev 2016; 25: 124-129
Year: 2016

Enablers, barriers, needs and preferences of physical activity in patients with COPD: does pulmonary rehabilitation play a role?
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019

Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020

Are genetic defects of dienin a key link in the pathogenesis of COPD?
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

The environment and the gut microbiome - interesting association or a rich field for future therapies?
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018

Interference RNA as a new tool and possible future therapy for inflammatory lung disease
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005

Identification of lung transplant candidates, stratification of risk, lung allocation and quality control in Europe using real-time decision-making and big data: lessons learned and future perspectives
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021

Is the association between physical activity and lung function due to reverse causation? An application of exploratory and causal approaches
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019

Rethinking the way we are treating established airway disease: current guidelines need to change 
Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma
Year: 2016

Pulmonologists and lung cancer: pivotal role in multidisciplinary approach
Source: Eur Respir J 2013; 42: 1183-1185
Year: 2013

The potential role of the green environment on respiratory health
Source: International Congress 2019 – Is your patient dying from air pollution?
Year: 2019

Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018

N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease
Source: Annual Congress 2010 - Scientific Year in Review
Year: 2010

Early origins of lung disease: towards an interdisciplinary approach
Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020
Year: 2020

Improving physical activity in lung disease: strategies and importance
Source: Annual Congress 2009 - Cournand Lecture
Year: 2009